Clinical Trial: Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07832708) titled 'Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults' on Sept. 16.

Brief Summary: The goal of this study is to evaluate the safety, tolerability, and pharmacokinetics of ABBV-1162 in healthy adults.

Study Start Date: Nov. 02

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ABBV-1162

Oral

DRUG: Placebo

Oral

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....